|
09 Mar 2020 |
AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19
|
|
09 Mar 2020 |
Bristol Myers Squibb Reports Primary Results of ELOQUENT-1 Study Evaluating Empliciti (elotuzumab) Plus Revlimid (lenalidomide) and Dexamethasone in Patients with Newly Diagnosed, Untreated Multiple Myeloma
|
|
09 Mar 2020 |
New report with sales data for recombinant therapeutic antibodies and proteins shows continued success of innovative antibodies
|
|
09 Mar 2020 |
MolMed signs a multi-year agreement and announces the beginning of a new collaboration in the field of T cell therapies
|
|
09 Mar 2020 |
CytoDyn Files IND and Protocol for Phase 2 Clinical Trial for Treatment of Patients with Coronavirus with Leronlimab (PRO 140)
|
|
09 Mar 2020 |
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
|
|
09 Mar 2020 |
Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed for the Treatment of Chronic Hepatitis B Virus Infection
|
|
09 Mar 2020 |
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
|
|
08 Mar 2020 |
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
|
|
08 Mar 2020 |
Shionogi and Tetra Therapeutics Entered into New Strategic Collaboration for BPN14770, the Drug Candidates for the Treatment of Brain Disorders Marked by Cognitive and Memory Deficits
|
|
08 Mar 2020 |
FDA Approves New Treatment for Adults with Cushing’s Disease
|
|
08 Mar 2020 |
European Commission Grants AbbVie Marketing Authorization Shortening MAVIRET® (glecaprevir/pibrentasvir) Treatment Duration to Eight Weeks for Treatment-Naïve Chronic HCV Patients with Genotype 3 and Compensated Cirrhosis
|
|
08 Mar 2020 |
Update on Phase III DANUBE trial for Imfinzi and tremelimumab in unresectable, Stage IV bladder cancer
|
|
06 Mar 2020 |
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
|
|
05 Mar 2020 |
Dynacure Announces First Patient Dosed in Phase 1 / 2 'UNITE-CNM' Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)
|
|
05 Mar 2020 |
Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus
|
|
05 Mar 2020 |
Debiopharm Advances into the Highly Anticipated Clinical Phase for their Potent WEE1 Inhibitor
|
|
05 Mar 2020 |
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930
|
|
05 Mar 2020 |
EpiVax Accelerates COVID-19 Vaccine Development with UGA's Center for Vaccines and Immunology
|
|
04 Mar 2020 |
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™
|
